Apply Today!

Diversity in Clinical Trials Career Development Program
  • Home
  • About Us
  • About the Program
    • The Need
    • Our Vision
    • Goals
    • Program Model
    • Key Program Elements
  • For Applicants
    • Application Information
    • Letter of Intent
    • Application
    • Informational Webinar
  • Nat'l Advisory Committee
  • In The News
  • Contact Us
  • FAQs
  • More
    • Home
    • About Us
    • About the Program
      • The Need
      • Our Vision
      • Goals
      • Program Model
      • Key Program Elements
    • For Applicants
      • Application Information
      • Letter of Intent
      • Application
      • Informational Webinar
    • Nat'l Advisory Committee
    • In The News
    • Contact Us
    • FAQs
Diversity in Clinical Trials Career Development Program
  • Home
  • About Us
  • About the Program
  • For Applicants
  • Nat'l Advisory Committee
  • In The News
  • Contact Us
  • FAQs

Application Information

Application Process

The BMSF DCTCDP application will be a 2-step process, which includes: 


1) Submission of a Letter of Intent (LOI), and 


2) Upon review, selected candidates will be invited to submit a full Application.

Candidate Eligibility Criteria

Candidate Profile

Eligible candidates will reflect the National Science Foundation (NSF) definition of underrepresented populations in the US Biomedical, Clinical, Behavioral and Social Sciences Research Enterprise:

  • African Americans or Blacks
  • Hispanics or Latinos
  • American Indians or Alaska Natives
  • Native Hawaiians
  • Other Pacific Islanders


OR have a demonstrated commitment to increasing diverse patient participation in clinical trials.


Citizenship or immigration status 

Eligible candidates will be US Citizens or Lawful Permanent Residents (LPRs) as defined by the US Department of Homeland Security. [NOTE: H-1B, J-1, & O-1 Visa holders are eligible; the Visa must be valid during the full 2-yr period]   


Professional degree 

Eligible candidates will hold the degree of MD, MD/PhD, DO or DO/PhD 


Career Phase

Early Stage Investigator (ESI): As defined by NIH, a new investigator who has completed his or her terminal research degree or medical residency—whichever date is later—within the past 10 years and has not yet competed successfully for a substantial, competing NIH research grant. (Applicants with an RO1 or RO1 equivalent are ineligible.)

Targeted Key Dates

Application Process Opens:

Letter of Intent & Invited Full Application

Jan 4, 2021

 

Application Closes: 

July 2, 2021

 

Selection Process: 

July 2 - Aug 31, 2021

 

Selection Announcement:

Sep 1, 2021

 

First Cohort Begins:

Nov 2021


Note: Dates are subject to change.

To learn more about the program...

Register to attend an informational webinar today!

Register

start the application Process and submit your LOI:

Apply Now

Copyright © 2020 Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program. All Rights Reserved.

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept